Diastolic function is more sensitive than GLS in identifing cardiotoxicity. The SAFE trial results

Back

ESC Professional Premium Access

Diastolic function is more sensitive than GLS in identifing cardiotoxicity. The SAFE trial results

Session: Cardiotoxicity of drugs and other therapies

Topic: Diastolic Ventricular Dysfunction

Speaker: Doctor M. Del Bene (Florence, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Maria Riccarda Del Bene

Careggi University Hospital (AOUC), Florence (Italy)

0 follower

6 more presentations in this session

Pre-diabetes is associated with increased cardiac events in cancer patients prescribed anthracyclines

Speaker: Doctor I. Cheang (Nanjing, CN)

Prognostic value of 6-minute walking test for early prediction of doxorubicin induced cardiotoxicity

Speaker: Mrs G. Muckiene (Kaunas, LT)

Usefulness of the baseline risk assessment guidelines to predict cancer therapy-related cardiac dysfunction in early-stage HER2 positive breast cancer

Speaker: Doctor G. Oristrell Santamaria (Barcelona, ES)

CerS2 ko in vivo reduces pro-inflammatory ceramides and improves doxorubicin mediated cardiotoxicity

Speaker: Doctor T. Kretzschmar (Jena, DE)

Initial phase of anthracycline cardiotoxicity involves metabolic switch and activation of cardiac fibroblasts

Speaker: Associate Professor K. Urbanek (Naples, IT)

Access the full session

Cardiotoxicity of drugs and other therapies

Speakers: Doctor M. Del Bene, Doctor I. Cheang, Mrs G. Muckiene, Doctor G. Oristrell Santamaria, Doctor T. Kretzschmar...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources